Atrial Fibrillation Trial, Recruiting (NCT06383975)

Atrial Fibrillation Trial, Recruiting NCT06383975 Sponsor: Sebastien Knecht Condition: Atrial Fibrillation

Printed from Voxsanity (voxsanity.com.au) — NCT06383975 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Atrial Fibrillation

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have persistent atrial fibrillation (an irregular heart rhythm lasting 7 days or more) that is still causing symptoms after already having a procedure called pulmonary vein isolation (PVI) to treat it

Who may not be able to join:

People whose atrial fibrillation has been continuous for 12 months or longer
People who have serious problems with their heart valves
People whose left atrial chamber (a section of the heart) is too large in volume, measuring more than 150mL
People whose left atrial chamber measures more than 60mm in a specific dimension measured by heart scan (confirm with trial site)
People whose heart's central dividing wall (septum) measures more than 15mm thick
People who are not expected to live longer than one year
People who weigh more than 150 kg
People who have any medical reason that makes a catheter ablation procedure (a procedure using thin, flexible tubes to correct heart rhythm) unsafe or unsuitable for them

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sébastien Knecht, MD, PhD, AZ Sint-Jan Brugge AV

Phone: 003250453293

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06383975

Sponsor: Sebastien Knecht

Phase: Not Applicable

Status: Recruiting

Condition: Atrial Fibrillation

Trial contact: 003250453293

More information: https://clinicaltrials.gov/study/NCT06383975

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have persistent atrial fibrillation (an irregular heart rhythm lasting 7 days or more) that is still causing symptoms after already having a procedure called pulmonary vein isolation (PVI) to treat it

Who may not be able to join:

People whose atrial fibrillation has been continuous for 12 months or longer
People who have serious problems with their heart valves
People whose left atrial chamber (a section of the heart) is too large in volume, measuring more than 150mL
People whose left atrial chamber measures more than 60mm in a specific dimension measured by heart scan (confirm with trial site)
People whose heart's central dividing wall (septum) measures more than 15mm thick
People who are not expected to live longer than one year
People who weigh more than 150 kg
People who have any medical reason that makes a catheter ablation procedure (a procedure using thin, flexible tubes to correct heart rhythm) unsafe or unsuitable for them

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Sebastien Knecht

Registry

ClinicalTrials.gov

Start date

15 May 2024

Est. completion

30 April 2027

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Atrial tachyarrhythmia recurrence within 12 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov